ATE333877T1 - Amlopidinbezylat-tabletten mit verbesserter stabilität - Google Patents

Amlopidinbezylat-tabletten mit verbesserter stabilität

Info

Publication number
ATE333877T1
ATE333877T1 AT02788262T AT02788262T ATE333877T1 AT E333877 T1 ATE333877 T1 AT E333877T1 AT 02788262 T AT02788262 T AT 02788262T AT 02788262 T AT02788262 T AT 02788262T AT E333877 T1 ATE333877 T1 AT E333877T1
Authority
AT
Austria
Prior art keywords
weight
tablets
improved stability
amlopidine
bezylate
Prior art date
Application number
AT02788262T
Other languages
English (en)
Inventor
Pal Fekete
Ignacz Maria Kiralyne
Peter Toempe
Laszlone Gora
Palne Szentgroti
Huszar Magdolna Leventiszne
Palne Thuroczi
Magyar Olga Lonkaine
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of ATE333877T1 publication Critical patent/ATE333877T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02788262T 2001-12-17 2002-12-17 Amlopidinbezylat-tabletten mit verbesserter stabilität ATE333877T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0105345A HU226642B1 (en) 2001-12-17 2001-12-17 Amlodipine bezylate tablets having extended stability and process for producing the same

Publications (1)

Publication Number Publication Date
ATE333877T1 true ATE333877T1 (de) 2006-08-15

Family

ID=90000366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02788262T ATE333877T1 (de) 2001-12-17 2002-12-17 Amlopidinbezylat-tabletten mit verbesserter stabilität

Country Status (17)

Country Link
EP (1) EP1458384B1 (de)
AT (1) ATE333877T1 (de)
AU (1) AU2002353242A1 (de)
BG (1) BG108807A (de)
CZ (1) CZ2004791A3 (de)
DE (1) DE60213464T2 (de)
EA (1) EA006826B1 (de)
ES (1) ES2269787T3 (de)
HR (1) HRP20040582B1 (de)
HU (1) HU226642B1 (de)
LT (1) LT5241B (de)
LV (1) LV13243B (de)
PL (1) PL370420A1 (de)
RS (1) RS54304A (de)
SK (1) SK2862004A3 (de)
UA (1) UA74968C2 (de)
WO (1) WO2003051364A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006059217A1 (en) * 2004-12-01 2006-06-08 Ranbaxy Laboratories Limited Stable solid dosage forms of amlodipine besylate and processes for their preparation
JO3239B1 (ar) 2008-09-22 2018-03-08 Novartis Ag تركيبات جالينية من مركبات عضوية
JP4954961B2 (ja) * 2008-10-06 2012-06-20 大日本住友製薬株式会社 光安定性の向上した組成物
JP5689052B2 (ja) * 2011-12-26 2015-03-25 大日本住友製薬株式会社 光安定性の向上した組成物
EP2814465B1 (de) 2012-02-17 2019-07-03 Egis Gyógyszergyár Zrt. Pharmazeutische formulierung mit erhöhter stabilität
PL236001B1 (pl) 2012-12-21 2020-11-30 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
DE19857716A1 (de) * 1998-12-15 2000-06-21 Bayer Ag Neue feste Formulierung von Metrifonat
WO2003032954A1 (en) * 2001-10-17 2003-04-24 Dr. Reddy's Laboratories Ltd. Stabilized pharmaceutical formulations containing amlodipine maleate

Also Published As

Publication number Publication date
SK2862004A3 (en) 2004-11-03
RS54304A (en) 2006-12-15
HRP20040582B1 (en) 2007-08-31
EP1458384A1 (de) 2004-09-22
HRP20040582A2 (en) 2005-02-28
BG108807A (en) 2005-03-31
WO2003051364A1 (en) 2003-06-26
ES2269787T3 (es) 2007-04-01
LV13243B (en) 2005-05-20
EA200400801A1 (ru) 2004-12-30
LT5241B (lt) 2005-07-25
EA006826B1 (ru) 2006-04-28
HUP0105345A3 (en) 2007-08-28
LT2004062A (en) 2005-02-25
CZ2004791A3 (cs) 2004-10-13
DE60213464D1 (de) 2006-09-07
EP1458384B1 (de) 2006-07-26
HUP0105345D0 (en) 2002-02-28
AU2002353242A1 (en) 2003-06-30
HUP0105345A2 (hu) 2003-12-29
HU226642B1 (en) 2009-05-28
DE60213464T2 (de) 2007-03-01
PL370420A1 (en) 2005-05-30
UA74968C2 (en) 2006-02-15

Similar Documents

Publication Publication Date Title
MXPA03006841A (es) 4-fluoro-n-indan-2-il-benzamida y su uso como producto farmaceutico.
MY148680A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
FI20011852A (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
NO20042844L (no) 4-(piperidyl- og pyrrolidyl-alkyl-ureido)-kinoliner som uprotensin II reseptor-antagonister
WO2001095856A3 (en) Urea derivative useful as an anti-cancer agent and process for preparing same
MY130441A (en) Solutions containing epinastin
MXPA04001686A (es) Combinaciones de productos activos fungicidas.
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
SE0102440D0 (sv) New compound
ATE333877T1 (de) Amlopidinbezylat-tabletten mit verbesserter stabilität
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
IL152337A0 (en) A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
ES2197781A1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
CA2338988A1 (en) Aqueous growth-regulating compositions
MXPA03004111A (es) Composiciones de n-(1 -metiletilaminocarbonil)-4 -(3-metilfenilamino) -3-piridil-sulfonamida y oligosacaridos ciclicos con una mayor liberacion.
AP2003002897A0 (en) Processes and intermediates for preparing benzyl epoxides
MY127289A (en) Caloporoside derivatives, process for the preparation thereof, and the use thereof
SE0002354D0 (sv) New formulation
HUP0401943A3 (en) The use of 2alfa,3alfa, 17alfa-trihydroxy-5alfa-androstan-6-one as active ingredient for plant development regulation via increasing stress

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1458384

Country of ref document: EP

REN Ceased due to non-payment of the annual fee